Literature DB >> 10806731

[Preliminary study on bone loss rate in early and late stages of post-menopausal women].

H Xu1, Y Wu, Y Yan.   

Abstract

OBJECTIVES: To investigate the characteristics of bone loss rate and bone turnover in early and late stages of normal chinese postmenopausal women, and to evaluate the predictive value of bone biochemical markers.
METHODS: Thirty-two early postmenopausal women (1-3 years after menopause, group 1) and 33 late ones (15-30 years after menopause, group 2) were enrolled. Serum and bone alkaline phosphotase (alkaline phosphotase, ALP; bone alkaline phosphotase, BAP), fasting uriuary calcium/creatinine ratio (Ca/Cr), and Pyridinoline/creatinine ratio (Pyd/Cr), serum osteocalcin(BGP), bone mineral density (BMD) were measured at laseline and 6 months, 12 month follow-up.
RESULTS: In group 1, mean lumber mineral density decreased 1.3% and 2.6% at 6 and 12 month follow-up as compared with initial values, In group 2, bone loss rates of femoral neck and Ward's triangle were 1.3%, 5.3% at 6 months, and 1.9%, 4.6% at 12 months respectively. Urinary Pyd/Cr elevated with time in the two groups. Changes of BGP, BAP in the two groups were similar. There were positive correlations between ALP, Ca/Cr, BGP, BAP and BMD. No correlation was found between bone loss rate of lumber spine and biochemical markers.
CONCLUSION: Lumber spine was the favorable site to assess rapid bone loss in early postmenopausal women. Femoral neck and Ward's triangle region were superior to other site in predicting slow bone loss. Bone turnover of the two groups were all accelerated. Single measurement of biochemical marker failed to predict bone loss rate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10806731

Source DB:  PubMed          Journal:  Zhonghua Fu Chan Ke Za Zhi        ISSN: 0529-567X


  1 in total

1.  Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : a single-blind randomized, placebo-controlled trial.

Authors:  Yan-Bin Ye; Xing-Yi Tang; Marian A Verbruggen; Yi-Xiang Su
Journal:  Eur J Nutr       Date:  2006-06-08       Impact factor: 5.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.